Related Experiment Video
Updated: Jun 26, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery
Damir Fabijanić1, Marko Banić, Dusko Kardum
1University Hospital Split, Split, Croatia. damir.fabijanic@st.t-com.hr
Insights
Elevated high-sensitivity C-reactive protein (hs-CRP) levels in coronary artery disease (CAD) patients may indicate upper gastrointestinal lesions (UGILs). Endoscopy is recommended for CAD patients with high hs-CRP to assess UGILs and manage cardiovascular risk.
Area of Science:
- Cardiology
- Gastroenterology
- Biomarkers
Background:
- High-sensitivity C-reactive protein (hs-CRP) is an independent predictor of cardiovascular events.
- A link between upper gastrointestinal lesions (UGILs) and coronary artery disease (CAD) has been observed.
- The study investigates the hypothesis that UGILs elevate hs-CRP in CAD patients.
Purpose of the Study:
- To determine if upper gastrointestinal lesions (UGILs) are associated with elevated high-sensitivity C-reactive protein (hs-CRP) levels in patients with coronary artery disease (CAD).
- To explore the correlation between the severity of UGILs and hs-CRP levels in CAD patients.
- To assess the clinical implications of this association for cardiovascular risk management.
Main Methods:
- 150 patients with stable coronary artery disease (CAD) were studied.
- Data on demographics, clinical variables, and medications were collected.
- Upper gastrointestinal lesion (UGIL) severity was assessed using the Lanza score, H. pylori status by histology, and CAD severity by the Gensini score.
- Logistic regression analysis was used to test the correlation between hs-CRP and UGILs.
Main Results:
- Patients with UGILs had significantly higher hs-CRP levels (8.14 mg/l) compared to those without (4.64 mg/l).
- hs-CRP levels showed a positive correlation with UGIL severity (r=0.434, P<0.0001).
- This correlation remained significant after adjusting for coronary risk factors, medications, CAD severity, and H. pylori status.
Conclusions:
- Elevated hs-CRP levels in CAD patients may serve as a predictor for underlying UGILs.
- Endoscopic evaluation is recommended for CAD patients with elevated hs-CRP, even in the absence of dyspeptic symptoms.
- UGILs, by increasing hs-CRP levels, might contribute to increased cardiovascular risk in these patients.
Background:
Although high-sensitivity C-reactive protein (hs-CRP) testing is not specific for coronary atherosclerosis, elevated hs-CRP is recently accepted as an independent predictor of future cardiovascular events. Also, a connection between upper gastrointestinal lesions (UGILs) and coronary artery disease (CAD) has been observed. The authors hypothesized that UGILs increase hs-CRP in CAD patients.
Material/Methods:
One hundred fifty patients with stable CAD were enrolled in the study. Demographic and clinical variables and chronic medication used were gathered from a structured questionnaire. UGIL severity was determined by a modified Lanza score, H. pylori status by histology of the gastric mucosa, and the severity of CAD by a modified Gensini score. Independent correlation between hs-CRP and UGIL was tested by logistic regression analysis.
Results:
The overall hs-CRP value was higher in patients with UGIL than in those with normal endoscopic results (8.14+/-4.53 mg/l vs. 4.64+/-3.06 mg/l, P<0.0001). hs-CRP level positively correlated with UGIL severity (r=0.434, P<0.0001). Correlation between UGIL and hs-CRP level remained significant after adjustment for coronary risk factors, medication used, CAD severity, and H. pylori status (standardized coefficient beta=1.272, P<0.0001). However, when hs-CRP level was used as a categorical variable, multivariate analysis revealed independent correlation only between UGIL and hs-CRP categories > or =6.1 mg/l.
Conclusions:
Elevated hs-CRP levels may be predictive of UGIL; thus endoscopy should be considered in CAD patients with elevated hs-CRP even with no dyspeptic symptoms. Because CRP plays an active role in atherothrombosis, UGILs with subsequent elevated CRP levels could increase cardiovascular risk in those patients.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Acute Coronary Syndrome I: Introduction